About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Safety Extension Study of DR-OXY-301

A Safety Extension Study of DR-OXY-301

NCT00782769·35 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Duramed Research

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Completed the 12 weeks of treatment in the DR-OXY-301 study
Willing to limit medications for overactive bladder to investigational product only
Able to understand and complete all study procedures including the required diary

The record

StatusCompleted

PhasePhase 3

Taking part240

StartedSep 2008

UpdatedMar 16, 2023

Conditions

Overactive Bladder

Where35

Duramed Investigational Site
Phoenix, Arizona, United States
Duramed Investigational Site
San Diego, California, United States
Duramed Investigational Site
San Diego, California, United States